Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Clinics and Research in Hepatology and Gastroenterology
|
November 19, 2018
Are there variations in adherence to colorectal cancer clinical guidelines depending on treatment place and recommendation novelty? The French EvaCCoR observational study
S Lamy, R Guimbaud, L Digue, et al.
Oncogene
|
November 14, 2006
Characterization of promoter regulatory elements involved in downexpression of the DNA polymerase kappa in colorectal cancer
F Lemée, C Bavoux, M J Pillaire, et al.
Familial Cancer
|
October 29, 2018
Germline mutation p.N363K in POLE is associated with an increased risk of colorectal cancer and giant cell glioblastoma
P Vande Perre, A Siegfried, C Corsini, et al.
European Cytokine Network
|
July 29, 1998
Effects of murine recombinant interleukin-10 on the inflammatory disease of rats transgenic for HLA-B27 and human beta 2-microglobulin
V Bertrand, S Quéré, R Guimbaud, et al.
Clinical Pharmacology and Therapeutics
|
October 3, 2000
Dose and time dependencies of 5-fluorouracil pharmacokinetics
C Terret, E Erdociain, R Guimbaud, et al.
ESMO Open
|
August 5, 2023
Evaluation of the relevance of the growth modulation index (GMI) from the FFCD 0307 randomized phase III trial comparing the sequence of two chemotherapeutic regimens
P du Rusquec, R Guimbaud, K Le Malicot, et al.
Gastrointestinal Endoscopy
|
December 1, 1998
Technetium Tc 99m hexamethyl propylene amine oxine leukocyte scintigraphy in patients with ulcerative colitis: correlation with clinical, biologic, endoscopic, and pathologic intensity, and local release of interleukin 8
R Guimbaud, E Beades, L Chauvelot-Moachon, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Genetic and transcriptomic analyses of early-onset colon cancer (EOCC): a <i>post hoc</i> analysis of 2973 patients from two adjuvant randomized trials
A Gandini, C Gallois, H Blons, et al.
Clinics and Research in Hepatology and Gastroenterology
|
June 3, 2011
Efficacy of irinotecan in combination with 5-fluorouracil (FOLFIRI) for metastatic gastric or gastroesophageal junction adenocarcinomas (MGA) treatment
E Samalin, P Afchain, S Thézenas, et al.
Medical Oncology (Northwood, London, England)
|
November 6, 2010
Feasibility of cetuximab given with a simplified schedule every 2 weeks in advanced colorectal cancer: a multicenter, retrospective analysis
M Bouchahda, T Macarulla, G Liedo, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Clinics and Research in Hepatology and Gastroenterology
|
November 19, 2018
Are there variations in adherence to colorectal cancer clinical guidelines depending on treatment place and recommendation novelty? The French EvaCCoR observational study
S Lamy, R Guimbaud, L Digue, et al.
Oncogene
|
November 14, 2006
Characterization of promoter regulatory elements involved in downexpression of the DNA polymerase kappa in colorectal cancer
F Lemée, C Bavoux, M J Pillaire, et al.
Familial Cancer
|
October 29, 2018
Germline mutation p.N363K in POLE is associated with an increased risk of colorectal cancer and giant cell glioblastoma
P Vande Perre, A Siegfried, C Corsini, et al.
European Cytokine Network
|
July 29, 1998
Effects of murine recombinant interleukin-10 on the inflammatory disease of rats transgenic for HLA-B27 and human beta 2-microglobulin
V Bertrand, S Quéré, R Guimbaud, et al.
Clinical Pharmacology and Therapeutics
|
October 3, 2000
Dose and time dependencies of 5-fluorouracil pharmacokinetics
C Terret, E Erdociain, R Guimbaud, et al.
ESMO Open
|
August 5, 2023
Evaluation of the relevance of the growth modulation index (GMI) from the FFCD 0307 randomized phase III trial comparing the sequence of two chemotherapeutic regimens
P du Rusquec, R Guimbaud, K Le Malicot, et al.
Gastrointestinal Endoscopy
|
December 1, 1998
Technetium Tc 99m hexamethyl propylene amine oxine leukocyte scintigraphy in patients with ulcerative colitis: correlation with clinical, biologic, endoscopic, and pathologic intensity, and local release of interleukin 8
R Guimbaud, E Beades, L Chauvelot-Moachon, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Genetic and transcriptomic analyses of early-onset colon cancer (EOCC): a <i>post hoc</i> analysis of 2973 patients from two adjuvant randomized trials
A Gandini, C Gallois, H Blons, et al.
Clinics and Research in Hepatology and Gastroenterology
|
June 3, 2011
Efficacy of irinotecan in combination with 5-fluorouracil (FOLFIRI) for metastatic gastric or gastroesophageal junction adenocarcinomas (MGA) treatment
E Samalin, P Afchain, S Thézenas, et al.
Medical Oncology (Northwood, London, England)
|
November 6, 2010
Feasibility of cetuximab given with a simplified schedule every 2 weeks in advanced colorectal cancer: a multicenter, retrospective analysis
M Bouchahda, T Macarulla, G Liedo, et al.
Page
of 6